New Delhi, Oct. 9 -- India is working on a plan to help domestic medical device makers cope with stiff US tariffs and regulations that make exports difficult and costly.

The Department of Pharmaceuticals' (DoP) plan could include subsidies for small and medium enterprises (SMEs) to reduce high compliance costs, mutual recognition agreements with the US Food and Drug Administration (US FDA) so that Indian products are accepted more easily, expansion of accredited testing labs, and setting up of a dedicated export facilitation desk to guide exporters through the procedures, according to documents reviewed by Mint and two people familiar with the matter.

Indian exporters currently face significant trade barriers, including high FDA registr...